Related Experiment Video

Updated: Jun 21, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis

Hailing Cheng1, Pixu Liu, Zhigang C Wang

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Science Signaling
|July 23, 2009
PubMed

Insights

Salt-inducible kinase 1 (SIK1) regulates anoikis, a cell death process crucial for preventing cancer metastasis. Loss of SIK1 impairs p53 function, promoting anchorage-independent growth and metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Death Pathways

Background:

  • Anoikis, a form of apoptosis induced by cell detachment, is a critical barrier against malignant transformation and metastasis.
  • The precise molecular mechanisms linking cell detachment to the tumor suppressor p53 remain largely undefined.

Purpose of the Study:

  • To identify novel regulators of p53-dependent anoikis.
  • To elucidate the role of SIK1 in anoikis and its implications for metastasis.

Main Methods:

  • Utilized a kinome-wide loss-of-function screen to identify kinases involved in anoikis.
  • Investigated the function of SIK1 in anoikis using cell-based assays and in vivo metastasis models.
  • Assessed the correlation between SIK1 expression and metastasis in human breast cancer cohorts.

Main Results:

  • SIK1 was identified as a key regulator of p53-dependent anoikis.
  • SIK1 inactivation compromised p53 function, promoting anchorage-independent growth and anoikis resistance.
  • Loss of SIK1 facilitated tumor cell survival, metastatic spread, and micrometastasis formation in vivo.
  • Functional SIK1 was essential for LKB1-mediated anoikis induction and suppression of metastatic potential.
  • Decreased SIK1 gene expression in human breast cancers correlated with the development of distal metastases.

Conclusions:

  • SIK1 acts as a crucial link between LKB1 and p53 in regulating anoikis.
  • SIK1 functions as a tumor suppressor by promoting anoikis and inhibiting metastasis.
  • SIK1 represents a potential therapeutic target for preventing cancer metastasis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...